首页 > 最新文献

Seminars in Ophthalmology最新文献

英文 中文
Intraoperative Intraocular Lens Waste: Incidence, Cost and Reasons. 术中眼内透镜浪费:发生率、成本和原因。
IF 1.9 4区 医学 Q2 OPHTHALMOLOGY Pub Date : 2024-11-01 Epub Date: 2024-05-19 DOI: 10.1080/08820538.2024.2354692
Junjie Cai, Yamin Li, Dongdong Pan, Xiaomeng Li, Nived Moonasar, Zhong Lin, Yinghui Shi, Jianxia Lin, Peihua Zhang

Purpose: To evaluate the incidence and cost of intraocular lens(IOL) waste during IOL implantation, as well as the reasons for it.

Methods: A retrospective analysis was conducted on the data of 485 patients from the IOL waste registers of a single tertiary eye hospital in China during 2016-2020. The primary outcomes were the incidence, cost, and reasons for different IOL properties. Cases were examined to ascertain IOL material, design, procedural details, and causes of waste.

Results: IOL waste occurred in 485 (6.62‰) of the 73,246 IOL implantations during the study period. The total cost of IOL waste was 429, 850.26 Chinese Yuan (CNY) related to waste with an average cost of 2, 442.33 CNY per procedure during the study period. Comparisons between IOL properties showed that polymethyl methacrylate (PMMA) material (39, 2.05%), three-piece design (142, 1.49%), and secondary IOL implantation (26, 2.16%) were associated with IOL wastage, and the difference was statistically significant. The causes of IOL waste were damage (107, 60.80%), patient reasons (37, 21.26%), aseptic errors (22, 12.50%), IOL quality problems (8, 4.55%), and loss (2, 1.14%).

Conclusions: The incidence of IOL waste is low, but still leads to a significant cost burden due to a large number of cataract surgeries. PMMA material, three-piece design, and secondary implantation were identified as factors increasing IOL waste. Damage emerged as the primary reason for waste, largely attributed to human error. Therefore, the development of strategies to mitigate IOL waste is imperative.

目的:评估人工晶体植入术中眼球内人工晶体(IOL)浪费的发生率、成本及其原因:方法:对中国一家三级眼科医院 2016-2020 年间人工晶体浪费登记册中 485 例患者的数据进行回顾性分析。主要结果是不同人工晶体属性的发生率、成本和原因。对病例进行检查,以确定人工晶体的材料、设计、手术细节以及造成浪费的原因:研究期间,在 73,246 例人工晶体植入手术中,有 485 例(6.62‰)发生了人工晶体废用。在研究期间,人工晶体浪费的总费用为 429 850.26 人民币,平均每例手术花费 2 442.33 人民币。对人工晶体性能的比较显示,聚甲基丙烯酸甲酯(PMMA)材料(39,2.05%)、三件式设计(142,1.49%)和二次人工晶体植入(26,2.16%)与人工晶体浪费有关,且差异具有统计学意义。造成人工晶体浪费的原因包括:损坏(107,60.80%)、患者原因(37,21.26%)、无菌操作失误(22,12.50%)、人工晶体质量问题(8,4.55%)和丢失(2,1.14%):人工晶体浪费的发生率很低,但由于白内障手术数量庞大,仍会造成巨大的成本负担。PMMA材料、三片式设计和二次植入被认为是增加人工晶体浪费的因素。损坏是造成浪费的主要原因,这主要归咎于人为错误。因此,制定减少人工晶体浪费的策略势在必行。
{"title":"Intraoperative Intraocular Lens Waste: Incidence, Cost and Reasons.","authors":"Junjie Cai, Yamin Li, Dongdong Pan, Xiaomeng Li, Nived Moonasar, Zhong Lin, Yinghui Shi, Jianxia Lin, Peihua Zhang","doi":"10.1080/08820538.2024.2354692","DOIUrl":"10.1080/08820538.2024.2354692","url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate the incidence and cost of intraocular lens(IOL) waste during IOL implantation, as well as the reasons for it.</p><p><strong>Methods: </strong>A retrospective analysis was conducted on the data of 485 patients from the IOL waste registers of a single tertiary eye hospital in China during 2016-2020. The primary outcomes were the incidence, cost, and reasons for different IOL properties. Cases were examined to ascertain IOL material, design, procedural details, and causes of waste.</p><p><strong>Results: </strong>IOL waste occurred in 485 (6.62‰) of the 73,246 IOL implantations during the study period. The total cost of IOL waste was 429, 850.26 Chinese Yuan (CNY) related to waste with an average cost of 2, 442.33 CNY per procedure during the study period. Comparisons between IOL properties showed that polymethyl methacrylate (PMMA) material (39, 2.05%), three-piece design (142, 1.49%), and secondary IOL implantation (26, 2.16%) were associated with IOL wastage, and the difference was statistically significant. The causes of IOL waste were damage (107, 60.80%), patient reasons (37, 21.26%), aseptic errors (22, 12.50%), IOL quality problems (8, 4.55%), and loss (2, 1.14%).</p><p><strong>Conclusions: </strong>The incidence of IOL waste is low, but still leads to a significant cost burden due to a large number of cataract surgeries. PMMA material, three-piece design, and secondary implantation were identified as factors increasing IOL waste. Damage emerged as the primary reason for waste, largely attributed to human error. Therefore, the development of strategies to mitigate IOL waste is imperative.</p>","PeriodicalId":21702,"journal":{"name":"Seminars in Ophthalmology","volume":" ","pages":"623-627"},"PeriodicalIF":1.9,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140956594","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lacrimal History - Part 11: Doyens of Dacryology Series - Johann Gottfried Zinn (1727-1759) and his Anatomy Treatise of 1755. 泪腺史 - 第 11 部分:泪腺学大师系列 - 约翰-戈特弗里德-津恩(Johann Gottfried Zinn,1727-1759 年)及其 1755 年的解剖学论文。
IF 1.9 4区 医学 Q2 OPHTHALMOLOGY Pub Date : 2024-10-28 DOI: 10.1080/08820538.2024.2422224
Mohammad Javed Ali
{"title":"Lacrimal History - Part 11: Doyens of Dacryology Series - Johann Gottfried Zinn (1727-1759) and his Anatomy Treatise of 1755.","authors":"Mohammad Javed Ali","doi":"10.1080/08820538.2024.2422224","DOIUrl":"https://doi.org/10.1080/08820538.2024.2422224","url":null,"abstract":"","PeriodicalId":21702,"journal":{"name":"Seminars in Ophthalmology","volume":" ","pages":"1-3"},"PeriodicalIF":1.9,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142522928","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Research Trends and Hotspots of Big Data in Ophthalmology: A Bibliometric Analysis and Visualization. 眼科大数据的研究趋势与热点:文献计量分析与可视化。
IF 1.9 4区 医学 Q2 OPHTHALMOLOGY Pub Date : 2024-10-26 DOI: 10.1080/08820538.2024.2421478
Jiawei Chen, Xiang-Ling Yuan, Zhimin Liao, Wenxiang Zhu, Xiaoyu Zhou, Xuanchu Duan

Purpose: The burst of modern information has significantly promoted the development of global medicine into a new era of big data healthcare. Ophthalmology is one of the most prominent medical specialties driven by big data analytics. This study aimed to describe the development status and research hotspots of big data in ophthalmology.

Methods: English articles and reviews related to big data in ophthalmology published from January 1, 1999, to April 30, 2024, were retrieved from the Web of Science Core Collection. The relevant information was analyzed and visualized using VOSviewer and CiteSpace software.

Results: A total of 406 qualified documents were included in the analysis. The annual number of publications on big data in ophthalmology reached a rapidly increasing stage since 2019. The United States (n = 147) led in the number of publications, followed by India (n = 77) and China (n = 69). The L.V. Prasad Eye Institute in India was the most productive institution (n = 50), and Anthony Vipin Das was the most influential author with the most relevant literature (n = 45). The electronic medical records were the primary source of ophthalmic big data, and artificial intelligence served as the principal analytics tool. Diabetic retinopathy, glaucoma, and myopia are currently the main topics of interest in this field.

Conclusions: The application of big data in ophthalmology has experienced rapid growth in recent years. Big data is expected to play an increasingly significant role in shaping the future of research and clinical practice in ophthalmology.

目的:现代信息的突飞猛进极大地推动了全球医学的发展,使其进入了大数据医疗的新时代。眼科是大数据分析推动下最突出的医学专科之一。本研究旨在阐述眼科大数据的发展现状和研究热点:从Web of Science核心文献库中检索了1999年1月1日至2024年4月30日期间发表的与眼科大数据相关的英文文章和综述。使用 VOSviewer 和 CiteSpace 软件对相关信息进行分析和可视化:共有 406 篇符合条件的文献被纳入分析。自2019年以来,眼科大数据的年度论文数量达到快速增长阶段。美国(n = 147)的论文数量居首位,其次是印度(n = 77)和中国(n = 69)。印度的L.V. Prasad眼科研究所是成果最多的机构(n = 50),Anthony Vipin Das是最有影响力的作者,相关文献最多(n = 45)。电子病历是眼科大数据的主要来源,人工智能是主要的分析工具。糖尿病视网膜病变、青光眼和近视是该领域目前主要关注的话题:近年来,大数据在眼科领域的应用快速增长。预计大数据将在塑造眼科研究和临床实践的未来方面发挥越来越重要的作用。
{"title":"Research Trends and Hotspots of Big Data in Ophthalmology: A Bibliometric Analysis and Visualization.","authors":"Jiawei Chen, Xiang-Ling Yuan, Zhimin Liao, Wenxiang Zhu, Xiaoyu Zhou, Xuanchu Duan","doi":"10.1080/08820538.2024.2421478","DOIUrl":"https://doi.org/10.1080/08820538.2024.2421478","url":null,"abstract":"<p><strong>Purpose: </strong>The burst of modern information has significantly promoted the development of global medicine into a new era of big data healthcare. Ophthalmology is one of the most prominent medical specialties driven by big data analytics. This study aimed to describe the development status and research hotspots of big data in ophthalmology.</p><p><strong>Methods: </strong>English articles and reviews related to big data in ophthalmology published from January 1, 1999, to April 30, 2024, were retrieved from the Web of Science Core Collection. The relevant information was analyzed and visualized using VOSviewer and CiteSpace software.</p><p><strong>Results: </strong>A total of 406 qualified documents were included in the analysis. The annual number of publications on big data in ophthalmology reached a rapidly increasing stage since 2019. The United States (<i>n</i> = 147) led in the number of publications, followed by India (<i>n</i> = 77) and China (<i>n</i> = 69). The L.V. Prasad Eye Institute in India was the most productive institution (<i>n</i> = 50), and Anthony Vipin Das was the most influential author with the most relevant literature (<i>n</i> = 45). The electronic medical records were the primary source of ophthalmic big data, and artificial intelligence served as the principal analytics tool. Diabetic retinopathy, glaucoma, and myopia are currently the main topics of interest in this field.</p><p><strong>Conclusions: </strong>The application of big data in ophthalmology has experienced rapid growth in recent years. Big data is expected to play an increasingly significant role in shaping the future of research and clinical practice in ophthalmology.</p>","PeriodicalId":21702,"journal":{"name":"Seminars in Ophthalmology","volume":" ","pages":"1-13"},"PeriodicalIF":1.9,"publicationDate":"2024-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142507450","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pupillary Peaking & Presence of Dysphotopsias Following Glaucoma Tube Shunt Surgery. 青光眼管分流手术后的瞳孔峰值和视力障碍。
IF 1.9 4区 医学 Q2 OPHTHALMOLOGY Pub Date : 2024-10-26 DOI: 10.1080/08820538.2024.2421475
Orlando G Gonzalez Martinez, Marko Oydanich, Siri Uppuluri, Rashika Verma, Albert S Khouri

Purpose: To describe the presence of pupillary peaking and dysphotopsias in a sample of eyes following glaucoma drainage device (GDD) surgery.

Methods: Cross-sectional analysis of 68 glaucoma patients with GDD, 45 patients with glaucoma and no GDD, and 50 control patients was conducted in a single academic center. Patients with an appropriate diagnosis that met the inclusion criteria were asked to enroll in the study. All patients received an 8-item dysphotopsia questionnaire and were age-matched. Photographs of pupils were taken to assess pupillary peaking. One-way analysis of variance (ANOVA) testing was performed for statistical analysis.

Results: Of the 68 patients with GDD, 25 (36.76%) had pupillary abnormalities with peaking most commonly occurring in the direction of the tube entry superotemporally, and 50 (73.53%) had reported one or more dysphotopsias. In patients reporting one or more dysphotopsias, the rate of lines, crescents, ghost images, and shadows was significantly higher when compared to glaucoma patients without GDD and control patients (p < .01). This corresponded to a lower best-corrected visual acuity in the GDD group compared to the glaucoma and control groups (p < .001).

Conclusions: Over a third of glaucoma patients receiving GDD had pupillary abnormalities, and nearly 3 out of 4 patients with GDD reported one or more dysphotopsias when compared to glaucoma patients without GDD and an age-matched control group. Glaucoma specialists and patients should be aware of these complications when proceeding with GDD surgery.

目的:描述青光眼引流装置(GDD)手术后眼球样本中是否存在瞳孔峰值和视力障碍:方法:在一个学术中心对 68 名接受 GDD 的青光眼患者、45 名未接受 GDD 的青光眼患者和 50 名对照组患者进行横断面分析。符合纳入标准的确诊患者被要求参加研究。所有患者都接受了一份包含 8 个项目的视力障碍问卷调查,并进行了年龄匹配。瞳孔照片用于评估瞳孔峰值。统计分析采用单因素方差分析(ANOVA):在 68 名 GDD 患者中,25 人(36.76%)有瞳孔异常,瞳孔峰值最常出现在颞上管入口方向,50 人(73.53%)报告了一次或多次视力障碍。与无 GDD 的青光眼患者和对照组患者相比,报告过一次或多次视力障碍的患者中,出现线条、新月、鬼影和阴影的比例明显更高(P P 结论):与未接受 GDD 的青光眼患者和年龄匹配的对照组相比,超过三分之一接受 GDD 的青光眼患者存在瞳孔异常,每 4 名 GDD 患者中就有近 3 人出现一种或多种视力障碍。青光眼专家和患者在进行 GDD 手术时应注意这些并发症。
{"title":"Pupillary Peaking & Presence of Dysphotopsias Following Glaucoma Tube Shunt Surgery.","authors":"Orlando G Gonzalez Martinez, Marko Oydanich, Siri Uppuluri, Rashika Verma, Albert S Khouri","doi":"10.1080/08820538.2024.2421475","DOIUrl":"https://doi.org/10.1080/08820538.2024.2421475","url":null,"abstract":"<p><strong>Purpose: </strong>To describe the presence of pupillary peaking and dysphotopsias in a sample of eyes following glaucoma drainage device (GDD) surgery.</p><p><strong>Methods: </strong>Cross-sectional analysis of 68 glaucoma patients with GDD, 45 patients with glaucoma and no GDD, and 50 control patients was conducted in a single academic center. Patients with an appropriate diagnosis that met the inclusion criteria were asked to enroll in the study. All patients received an 8-item dysphotopsia questionnaire and were age-matched. Photographs of pupils were taken to assess pupillary peaking. One-way analysis of variance (ANOVA) testing was performed for statistical analysis.</p><p><strong>Results: </strong>Of the 68 patients with GDD, 25 (36.76%) had pupillary abnormalities with peaking most commonly occurring in the direction of the tube entry superotemporally, and 50 (73.53%) had reported one or more dysphotopsias. In patients reporting one or more dysphotopsias, the rate of lines, crescents, ghost images, and shadows was significantly higher when compared to glaucoma patients without GDD and control patients (<i>p</i> < .01). This corresponded to a lower best-corrected visual acuity in the GDD group compared to the glaucoma and control groups (<i>p</i> < .001).</p><p><strong>Conclusions: </strong>Over a third of glaucoma patients receiving GDD had pupillary abnormalities, and nearly 3 out of 4 patients with GDD reported one or more dysphotopsias when compared to glaucoma patients without GDD and an age-matched control group. Glaucoma specialists and patients should be aware of these complications when proceeding with GDD surgery.</p>","PeriodicalId":21702,"journal":{"name":"Seminars in Ophthalmology","volume":" ","pages":"1-6"},"PeriodicalIF":1.9,"publicationDate":"2024-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142507449","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Application of Artificial Intelligence in the Diagnosis, Follow-Up and Prediction of Treatment of Ophthalmic Diseases. 人工智能在眼科疾病诊断、跟踪和治疗预测中的应用。
IF 1.9 4区 医学 Q2 OPHTHALMOLOGY Pub Date : 2024-10-22 DOI: 10.1080/08820538.2024.2414353
Jinwei Yu, Fuqiang Li, Mingzhu Liu, Mengdi Zhang, Xiaoli Liu

Purpose: To describe the application of artificial intelligence (AI) in ophthalmic diseases and its possible future directions.

Methods: A retrospective review of the literature from PubMed, Web of Science, and Embase databases (2019-2024).

Results: AI assists in cataract diagnosis, classification, preoperative lens calculation, surgical risk, postoperative vision prediction, and follow-up. For glaucoma, AI enhances early diagnosis, progression prediction, and surgical risk assessment. It detects diabetic retinopathy early and predicts treatment effects for diabetic macular edema. AI analyzes fundus images for age-related macular degeneration (AMD) diagnosis and risk prediction. Additionally, AI quantifies and grades vitreous opacities in uveitis. For retinopathy of prematurity, AI facilitates disease classification, predicting disease occurrence and severity. Recently, AI also predicts systemic diseases by analyzing fundus vascular changes.

Conclusions: AI has been extensively used in diagnosing, following up, and predicting treatment outcomes for common blinding eye diseases. In addition, it also has a unique role in the prediction of systemic diseases.

目的:描述人工智能(AI)在眼科疾病中的应用及其未来可能的发展方向:对PubMed、Web of Science和Embase数据库(2019-2024年)中的文献进行回顾性综述:人工智能有助于白内障的诊断、分类、术前晶状体计算、手术风险、术后视力预测和随访。对于青光眼,人工智能可加强早期诊断、病情发展预测和手术风险评估。它能早期检测糖尿病视网膜病变,预测糖尿病黄斑水肿的治疗效果。人工智能分析眼底图像,用于老年性黄斑变性(AMD)的诊断和风险预测。此外,人工智能还能对葡萄膜炎的玻璃体混浊进行量化和分级。对于早产儿视网膜病变,人工智能有助于疾病分类,预测疾病的发生和严重程度。最近,人工智能还通过分析眼底血管变化来预测全身性疾病:结论:人工智能已被广泛应用于常见致盲眼病的诊断、随访和治疗效果预测。结论:人工智能已被广泛应用于常见致盲眼病的诊断、随访和治疗效果预测,此外,它在预测全身性疾病方面也有独特的作用。
{"title":"Application of Artificial Intelligence in the Diagnosis, Follow-Up and Prediction of Treatment of Ophthalmic Diseases.","authors":"Jinwei Yu, Fuqiang Li, Mingzhu Liu, Mengdi Zhang, Xiaoli Liu","doi":"10.1080/08820538.2024.2414353","DOIUrl":"10.1080/08820538.2024.2414353","url":null,"abstract":"<p><strong>Purpose: </strong>To describe the application of artificial intelligence (AI) in ophthalmic diseases and its possible future directions.</p><p><strong>Methods: </strong>A retrospective review of the literature from PubMed, Web of Science, and Embase databases (2019-2024).</p><p><strong>Results: </strong>AI assists in cataract diagnosis, classification, preoperative lens calculation, surgical risk, postoperative vision prediction, and follow-up. For glaucoma, AI enhances early diagnosis, progression prediction, and surgical risk assessment. It detects diabetic retinopathy early and predicts treatment effects for diabetic macular edema. AI analyzes fundus images for age-related macular degeneration (AMD) diagnosis and risk prediction. Additionally, AI quantifies and grades vitreous opacities in uveitis. For retinopathy of prematurity, AI facilitates disease classification, predicting disease occurrence and severity. Recently, AI also predicts systemic diseases by analyzing fundus vascular changes.</p><p><strong>Conclusions: </strong>AI has been extensively used in diagnosing, following up, and predicting treatment outcomes for common blinding eye diseases. In addition, it also has a unique role in the prediction of systemic diseases.</p>","PeriodicalId":21702,"journal":{"name":"Seminars in Ophthalmology","volume":" ","pages":"1-9"},"PeriodicalIF":1.9,"publicationDate":"2024-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142486251","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lacrimal History - Part X: Doyens of Dacryology Series - Sir Percivall Pott (1714-1788) and His Lacrimal Treatise of 1758. 泪腺史 - 第十部分:泪腺学大师系列 - 珀西瓦尔-波特爵士(1714-1788 年)及其 1758 年的泪腺论文。
IF 1.9 4区 医学 Q2 OPHTHALMOLOGY Pub Date : 2024-10-20 DOI: 10.1080/08820538.2024.2417614
Mohammad Javed Ali
{"title":"Lacrimal History - Part X: Doyens of Dacryology Series - Sir Percivall Pott (1714-1788) and His Lacrimal Treatise of 1758.","authors":"Mohammad Javed Ali","doi":"10.1080/08820538.2024.2417614","DOIUrl":"https://doi.org/10.1080/08820538.2024.2417614","url":null,"abstract":"","PeriodicalId":21702,"journal":{"name":"Seminars in Ophthalmology","volume":" ","pages":"1-4"},"PeriodicalIF":1.9,"publicationDate":"2024-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142474221","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Immediate Postoperative Difference of Eyelid Height Based on Intraoperative Measurement of Levator Aponeurosis Advancement in Patients with Unilateral Ptosis. 根据术中测量单侧上睑下垂患者提上睑肌前移量得出的术后即刻眼睑高度差。
IF 1.9 4区 医学 Q2 OPHTHALMOLOGY Pub Date : 2024-10-14 DOI: 10.1080/08820538.2024.2416059
Jose Miguel Ambat, Steffani Krista Someda, Naoyuki Morishige, Yasuhiro Takahashi, Hirohiko Kakizaki

Purpose: To determine the relationship between marginal reflex distance (MRD-1) outcomes and the distance of levator aponeurosis advancement.

Methods: This retrospective observational study included patients with acquired unilateral aponeurotic ptosis, who underwent small-incision anterior levator advancement. The distance of levator advancement, and intra-operative MRD-1 in the sitting position, were analyzed to determine a correlation between the two.

Results: Forty-eight patients were included. Results exhibited no direct relationship between advancement distance and MRD-1 measurements. Median and range of MRD-1 outcomes did not present a linear progression as the distance increased or decreased. A majority of advancement distances exhibited a median MRD-1 outcome of 4.00 mm (n = 3). Success criteria was met in 85.4% of surgeries performed.

Conclusion: Due to varying postoperative MRD-1 outcomes, surgical results cannot be accurately predicted using predetermined advancement distances. Confirming the final MRD-1 in the sitting position with subsequent adjustment is still recommended.

目的:确定边缘反射距离(MRD-1)结果与上睑提肌腱膜前移距离之间的关系:这项回顾性观察研究纳入了接受小切口前上睑提肌腱膜前移术的后天性单侧上睑下垂患者。分析了上睑提肌前移的距离和术中坐位的 MRD-1,以确定两者之间的相关性:结果:共纳入 48 例患者。结果:共纳入 48 例患者,结果显示推进距离与 MRD-1 测量值之间没有直接关系。MRD-1结果的中位数和范围并没有随着距离的增减而呈现线性变化。大多数推进距离的 MRD-1 结果中位数为 4.00 毫米(n = 3)。85.4%的手术符合成功标准:结论:由于术后MRD-1结果各不相同,因此不能使用预先确定的推进距离来准确预测手术结果。仍建议在坐位时确认最终的 MRD-1,然后再进行调整。
{"title":"Immediate Postoperative Difference of Eyelid Height Based on Intraoperative Measurement of Levator Aponeurosis Advancement in Patients with Unilateral Ptosis.","authors":"Jose Miguel Ambat, Steffani Krista Someda, Naoyuki Morishige, Yasuhiro Takahashi, Hirohiko Kakizaki","doi":"10.1080/08820538.2024.2416059","DOIUrl":"https://doi.org/10.1080/08820538.2024.2416059","url":null,"abstract":"<p><strong>Purpose: </strong>To determine the relationship between marginal reflex distance (MRD-1) outcomes and the distance of levator aponeurosis advancement.</p><p><strong>Methods: </strong>This retrospective observational study included patients with acquired unilateral aponeurotic ptosis, who underwent small-incision anterior levator advancement. The distance of levator advancement, and intra-operative MRD-1 in the sitting position, were analyzed to determine a correlation between the two.</p><p><strong>Results: </strong>Forty-eight patients were included. Results exhibited no direct relationship between advancement distance and MRD-1 measurements. Median and range of MRD-1 outcomes did not present a linear progression as the distance increased or decreased. A majority of advancement distances exhibited a median MRD-1 outcome of 4.00 mm (<i>n</i> = 3). Success criteria was met in 85.4% of surgeries performed.</p><p><strong>Conclusion: </strong>Due to varying postoperative MRD-1 outcomes, surgical results cannot be accurately predicted using predetermined advancement distances. Confirming the final MRD-1 in the sitting position with subsequent adjustment is still recommended.</p>","PeriodicalId":21702,"journal":{"name":"Seminars in Ophthalmology","volume":" ","pages":"1-5"},"PeriodicalIF":1.9,"publicationDate":"2024-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142474219","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dual Sectoral Iris Prosthesis Implantation in Post-Traumatic Aniridia. 创伤后虹膜失认的双扇形虹膜假体植入术
IF 1.9 4区 医学 Q2 OPHTHALMOLOGY Pub Date : 2024-10-10 DOI: 10.1080/08820538.2024.2415427
Vijay Kumar Sharma, Prabhjot Singh, Vikas Ambiya, Srishti Khullar, Gaurav Kapoor
{"title":"Dual Sectoral Iris Prosthesis Implantation in Post-Traumatic Aniridia.","authors":"Vijay Kumar Sharma, Prabhjot Singh, Vikas Ambiya, Srishti Khullar, Gaurav Kapoor","doi":"10.1080/08820538.2024.2415427","DOIUrl":"https://doi.org/10.1080/08820538.2024.2415427","url":null,"abstract":"","PeriodicalId":21702,"journal":{"name":"Seminars in Ophthalmology","volume":" ","pages":"1-3"},"PeriodicalIF":1.9,"publicationDate":"2024-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142401200","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vitrectomy Combined with Repeated Intravitreal Injection of Ceftazidime for the Treatment of Brucellosis Endophthalmitis: A Case Report and Literature Review. 玻璃体切割联合重复玻璃体内注射头孢唑肟治疗布鲁氏菌病眼内炎:病例报告与文献综述。
IF 1.9 4区 医学 Q2 OPHTHALMOLOGY Pub Date : 2024-10-03 DOI: 10.1080/08820538.2024.2412050
Nan Guo, Yu-Jia Gui, Ying Chen

Purpose: To present a treatment regimen for Brucellosis endophthalmitis that resulted in a good visual outcome. Additionally, we conducted a literature review on the treatment and visual prognosis of related cases.

Case presentation: A 49-year-old woman with the chief complaint of decreased vision and redness in the right eye was initially diagnosed with noninfectious uveitis and prescribed high-dose steroids which led to transient improvement followed by a decline in vision. An infectious cause was suspected. Metagenomic next-generation sequencing of vitreous fluid and serological testing confirmed Brucella melitensis infection. The patient underwent vitrectomy combined with six intravitreal injections of ceftazidime in the right eye in addition to systemic antibiotic treatment. The intraocular inflammation was completely resolved, and the visual acuity recovered to 20/25, which is the best-documented recovery in Brucella endophthalmitis cases, as revealed by the literature review.

Conclusion: Vitrectomy combined with repeated intravitreal injections of ceftazidime can enhance the treatment for brucellosis endophthalmitis and achieve a better visual prognosis.

目的:介绍一种治疗布鲁氏菌眼内炎的方案,该方案可获得良好的视觉效果。此外,我们还对相关病例的治疗和视觉预后进行了文献综述:一名 49 岁的女性,主诉为视力下降和右眼发红,起初被诊断为非感染性葡萄膜炎,医生给她开了大剂量类固醇,结果一过性好转,随后视力下降。怀疑是感染所致。玻璃体液的元基因组下一代测序和血清学检测证实了布鲁氏菌感染。患者接受了玻璃体切除术,除了全身抗生素治疗外,还在右眼进行了六次头孢他啶玻璃体内注射。眼内炎症完全消退,视力恢复到 20/25,这是文献综述显示的布鲁氏菌眼内炎病例中恢复最好的记录:结论:玻璃体切割联合反复玻璃体内注射头孢唑肟可提高布鲁氏菌眼内炎的治疗效果,并获得更好的视力预后。
{"title":"Vitrectomy Combined with Repeated Intravitreal Injection of Ceftazidime for the Treatment of Brucellosis Endophthalmitis: A Case Report and Literature Review.","authors":"Nan Guo, Yu-Jia Gui, Ying Chen","doi":"10.1080/08820538.2024.2412050","DOIUrl":"https://doi.org/10.1080/08820538.2024.2412050","url":null,"abstract":"<p><strong>Purpose: </strong>To present a treatment regimen for Brucellosis endophthalmitis that resulted in a good visual outcome. Additionally, we conducted a literature review on the treatment and visual prognosis of related cases.</p><p><strong>Case presentation: </strong>A 49-year-old woman with the chief complaint of decreased vision and redness in the right eye was initially diagnosed with noninfectious uveitis and prescribed high-dose steroids which led to transient improvement followed by a decline in vision. An infectious cause was suspected. Metagenomic next-generation sequencing of vitreous fluid and serological testing confirmed Brucella melitensis infection. The patient underwent vitrectomy combined with six intravitreal injections of ceftazidime in the right eye in addition to systemic antibiotic treatment. The intraocular inflammation was completely resolved, and the visual acuity recovered to 20/25, which is the best-documented recovery in Brucella endophthalmitis cases, as revealed by the literature review.</p><p><strong>Conclusion: </strong>Vitrectomy combined with repeated intravitreal injections of ceftazidime can enhance the treatment for brucellosis endophthalmitis and achieve a better visual prognosis.</p>","PeriodicalId":21702,"journal":{"name":"Seminars in Ophthalmology","volume":" ","pages":"1-4"},"PeriodicalIF":1.9,"publicationDate":"2024-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142366451","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk of Posterior Capsule Ruptures in Fellow-Eye Cataract Surgeries: A Multicenter Comparative Study. 同眼白内障手术中后囊破裂的风险:一项多中心比较研究
IF 1.9 4区 医学 Q2 OPHTHALMOLOGY Pub Date : 2024-10-01 DOI: 10.1080/08820538.2024.2409154
Abdelrahman M Elhusseiny, Joseph Toma, S Nazem Ibrahim, Muhammad Z Chauhan, Kaersti L Rickels, Qais Dihan, Mohamed K Soliman, Yit C Yang, Ahmed B Sallam

Purpose: To quantify the risk of posterior capsule rupture (PCR) in fellow-eye phacoemulsification surgery and to determine risk factors.

Methods: We pooled data from 8 United Kingdom sites for patients undergoing bilateral non-simultaneous phacoemulsification. Main outcome measures were the incidence and risk factors of the development of PCR during the fellow-eye phacoemulsification.

Results: We included 66,288 patients with a mean age of 75.3 ± 10.2 years. PCR during phacoemulsification occurred in the first eye in 932 patients (1.4%) and the fellow eye in 1039 patients (1.5%). The risk of fellow eye developing PCR in patients with PCR in the first eye was significantly higher than in patients without first eye PCR: 30 patients (3.2%) vs. 1009 (1.5%), respectively (odds ratio (OR) = 1.7, 95% confidence interval (CI) = 1.1-2.7). Other risk factors for fellow-eye PCR included zonular dialysis (OR = 5.4, CI = 3.3-7.8) and advanced cataract (OR = 2.8, CI = 2.1-3.7).

Conclusions: History of PCR in the first-operated eye is an independent risk factor for PCR in the fellow eye.

目的:量化同眼超声乳化手术中后囊破裂(PCR)的风险,并确定风险因素:我们汇集了来自英国 8 个研究机构的数据,这些数据均来自接受双侧非同期超声乳化手术的患者。主要结果指标为同眼乳化手术中 PCR 的发生率和风险因素:我们共纳入了 66288 名患者,平均年龄为(75.3 ± 10.2)岁。932名患者(1.4%)的第一只眼和1039名患者(1.5%)的同眼在乳化过程中发生了PCR。首眼发生 PCR 的患者同眼发生 PCR 的风险明显高于首眼未发生 PCR 的患者:分别为 30 名患者(3.2%)和 1009 名患者(1.5%)(几率比(OR)= 1.7,95% 置信区间(CI)= 1.1-2.7)。同眼 PCR 的其他风险因素包括宗性透析(OR = 5.4,CI = 3.3-7.8)和晚期白内障(OR = 2.8,CI = 2.1-3.7):结论:第一只手术眼的 PCR 病史是导致同侧眼 PCR 的独立风险因素。
{"title":"Risk of Posterior Capsule Ruptures in Fellow-Eye Cataract Surgeries: A Multicenter Comparative Study.","authors":"Abdelrahman M Elhusseiny, Joseph Toma, S Nazem Ibrahim, Muhammad Z Chauhan, Kaersti L Rickels, Qais Dihan, Mohamed K Soliman, Yit C Yang, Ahmed B Sallam","doi":"10.1080/08820538.2024.2409154","DOIUrl":"https://doi.org/10.1080/08820538.2024.2409154","url":null,"abstract":"<p><strong>Purpose: </strong>To quantify the risk of posterior capsule rupture (PCR) in fellow-eye phacoemulsification surgery and to determine risk factors.</p><p><strong>Methods: </strong>We pooled data from 8 United Kingdom sites for patients undergoing bilateral non-simultaneous phacoemulsification. Main outcome measures were the incidence and risk factors of the development of PCR during the fellow-eye phacoemulsification.</p><p><strong>Results: </strong>We included 66,288 patients with a mean age of 75.3 ± 10.2 years. PCR during phacoemulsification occurred in the first eye in 932 patients (1.4%) and the fellow eye in 1039 patients (1.5%). The risk of fellow eye developing PCR in patients with PCR in the first eye was significantly higher than in patients without first eye PCR: 30 patients (3.2%) vs. 1009 (1.5%), respectively (odds ratio (OR) = 1.7, 95% confidence interval (CI) = 1.1-2.7). Other risk factors for fellow-eye PCR included zonular dialysis (OR = 5.4, CI = 3.3-7.8) and advanced cataract (OR = 2.8, CI = 2.1-3.7).</p><p><strong>Conclusions: </strong>History of PCR in the first-operated eye is an independent risk factor for PCR in the fellow eye.</p>","PeriodicalId":21702,"journal":{"name":"Seminars in Ophthalmology","volume":" ","pages":"1-6"},"PeriodicalIF":1.9,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142353360","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Seminars in Ophthalmology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1